Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 1.25 p.m. |
More news
-
15 October 2025
Blaauw Sterrenwacht geopend tijdens Nacht van de Nacht
De Blaauw Sterrenwacht van de Rijksuniversiteit Groningen is geopend tijdens de Nacht van de Nacht op zaterdag 25 oktober 2025. Tijdens deze nacht, waarin we de klok een uur terugzetten, kunnen bezoekers sterrenkijken en zijn er allerlei...
-
08 October 2025
Not all plastic needs to be bio-based or biodegradable
Per person, we throw away about 33 kilos of plastic packaging per year. Professor of Polymer Chemistry Katja Loos is working on a more sustainable future for plastics - by looking at more than the material itself.
-
06 October 2025
The GenAI-bubble will burst, but don’t give up on AI altogether
'People keep promoting the belief that generative AI provides universal tools that are capable of much more,’ says Michael Biehl, Professor of Machine Learning. ‘Sooner or later, the genAI bubble will burst,’ he is certain. But that doesn’t mean all...